LDOS stock · LIMNW stock

LDOS vs LIMNW

Leidos Holdings Inc (LDOS) versus Liminatus Pharma, Inc. Warrants (LIMNW) — a side-by-side from cached financials, not a winner call.

Leidos Holdings Inc (LDOS) is a information technology services company listed on US.

Liminatus Pharma, Inc. Warrants (LIMNW) is a biotechnology company listed on US.

Latest reported LDOS revenue for 2026-07-03 was $8.96B. Net income was $682.0M. LDOS currently screens at market cap $20.04B and trailing P/E 15.7.

LIMNW does not have a complete income-statement cache yet.

LDOS currently screens at market cap $20.04B and trailing P/E 15.7. LIMNW currently screens at market cap $0.

Not investment advice. Open the LDOS and LIMNW stock pages for the full models.

Not investment advice.

Popular Stock Comparisons